Comparison of Clinical Outcomes of Overlapping Sirolimus- Versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 98, Issue 12, 2006, Pages 1563-1566

  Chu, William W ^a   Kuchulakanti, Pramod K ^a   Torguson, Rebecca ^a   Wang, Betty ^a   Clavijo, Leonardo C ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DRUG IMPLANTATION; FEMALE; FOLLOW UP; HEART INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 37349065120     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.032     Document Type: Article

References (13)

1. Kastrati A., Elezi S., Dirschinger J., Hadamitzky M., Neumann F.J., and Schomig A. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83 (1999) 1617-1622
2. Lee S.H., Jang Y., Oh S.J., Park K.J., Moon Y.S., Min J.W., Yang J.Y., and Jang G.J. Overlapping vs. one long stenting in long coronary lesions. Catheter Cardiovasc Interv 62 (2004) 298-302
3. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
4. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
5. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
6. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
7. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
8. Morice M.-C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., and Stoll H.-P. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial. JAMA 295 (2006) 895-904
9. Windecker S., Remondino A., Eberli F.R., Jüni P., Räber L., Wenaweser P., Togni M., Billinger M., Tüller D., Seiler C., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
10. Stone G.W., Ellis S.G., O'Shaughnessy, et al., TAXUS V ISR Investigators. Paclitaxel-eluting stents versus vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 295 (2006) 1253-1263
11. Ryan T.J., Faxon D.P., Gunnar R.M., Kennedy J.W., King III S.B., Loop F.D., Peterson K.L., Reeves T.J., Williams D.O., and Winters W.L. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78 (1988) 486-502
12. Degertekin M., Arampatzis C.A., Lemos P.A., Saia F., Hoye A., Daemen J., Tanabe K., Lee C.H., Hofma S.J., Sianos G., et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 93 (2004) 826-829
13. Chu W.W., Kuchulakanti P.K., Torguson R., Wang B., Clavijo L.C., Suddath W.O., Pichard A.D., Satler L.F., Kent K.M., and Waksman R. Clinical outcomes of overlapping versus nonoverlapping sirolimus-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 67 (2006) 595-599